Potentiation and inhibition of neuronal nicotinic receptors by atropine: Competitive and noncompetitive effects

Molecular Pharmacology

Volumn 52, Issue 5, 1997, Pages 886-895

  Zwart, Ruud ^a   Vijverberg, Henk P M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZOIC ACID; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; ACETYLCHOLINE; ATROPINE; COLLAGENASE; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINE TARTRATE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; FEMALE; ION CURRENT; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; VOLTAGE CLAMP; XENOPUS LAEVIS;

EID: 0030842275     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.5.886     Document Type: Article

References (37)

1. Dale, H. H. The action of certain esters and ethers of choline and their relation to muscarine. J. Pharmacol. Exp. Ther. 6:147-190 (1914).
2. Koelle, G. B. Acetylcholine, in Encyclopedia of Neuroscience, Vol. I. (G. Adelman, ed.). Birkhauser, Boston/Basel/Stuttgart, 1-2 (1987).
3. Changeux, J. P. Acetylcholine receptor, in Encyclopedia of Neuroscience, Vol. I. (G. Adelman, ed.). Birkhauser, Boston/Basel/Stuttgart, 2-3 (1987).
4. Bonner, T. I., A. C. Young, M. R. Brann, and N. J. Buckley. Identification of a family of muscarinic acetylcholine receptor genes. Science (Washington D. C.) 237:527-532 (1987).
5. Hosey, M. M. Diversity of structure, signalling and regulation within the family of muscarinic cholinergic receptors. FASEB J. 6:845-852 (1992).
6. Sargent, P. B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:403-443 (1993).
7. Richards, M. H. Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochem. Pharmacol. 42:1645-1653 (1991).
8. Adler, M., E. X. Albuquerque, and F. J. Lebeda. Kinetic analysis of endplate currents altered by atropine and scopolamine. Mol. Pharmacol. 14:514-529 (1978).
9. Connor, E. A., S. M. Levy, and R. L. Parsons. Kinetic analysis of atropine-induced alterations in bullfrog ganglionic fast synaptic currents. J. Physiol. (Lond.) 337:137-158 (1983).
10. Feltz, A., W. A. Large, and A. Trautmann. Analysis of atropine action at the frog neuromuscular junction. J. Physiol. (Lond.) 269:109-130 (1977).
11. McGehee, D. S., and L. W. Role. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:521-546 (1995).
12. Gerzanich, V., R. Anand, and J. Lindstrom. Homomers of α8 and α7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol. Pharmacol. 45:212-220 (1994).
13. Elgoyhen, A. B., D. S. Johnson, J. Boulter, D. E. Vetter, and S. F. Heinemann. α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79:705-715 (1994).
14. 3 channels in rat nodose ganglion neurons. Neuroscience 62:1287-1292 (1994).
15. Deneris, E. S., J. Connolly, S. W. Rogers, and R. Duvoisin. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol. Sci. 12:34-40 (1991).
16. Zwart, R., and H. P. M. Vijverberg. Atropine inhibits neuronal nicotinic receptors. Soc. Neurosci. Abstr. 22:1522 (1996).
17. Stühmer, W. Electrophysiological recording from Xenopus oocytes. Methods Enzymol. 207:319-339 (1992).
18. Marquardt, D. W. An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Indust. Appl. Math. 11:431-141 (1963).
19. Kusano, K., R. Miledi, and J. Stinnakre. Cholinergic and catecholaminergic receptors in the Xenopus oocyte membrane. J. Physiol. (Lond.) 328:143-170 (1982).
20. Dascal, N., E. M. Landau, and Y. Lass. Xenopus oocytes resting potential, muscarinic responses and the role of calcium and guanosine 3′,5′-cyclic monophosphate. J. Physiol. (Lond.) 352:551-574 (1984).
21. Oortgiesen, M., and H. P. M. Vijverberg. Properties of neuronal type acetylcholine receptors in voltage clamped mouse neuroblastoma cells. Neuroscience 31:169-179 (1989).
22. Cachelin, A. B., and G. Rust. Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing β4 subunits. Mol. Pharmacol. 46:1168-1174 (1994).
23. Garcia-Colunga, J., and R. Miledi. Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. USA 92:2919-2923 (1995).
24. Lester, R. A. J., and J. A. Dani. Acetylcholine receptor desensitization induced by nicotine in rat medial habenula neurons. J. Neurophysiol. 74:195-206 (1995).
25. Zwart, R., M. Oortgiesen, and H. P. M. Vijverberg. Differential modulation of α3β2 and α3β4 neuronal nicotinic receptors expressed in Xenopus oocytes by flufenamic acid and niflumic acid. J. Neurosci. 15:2168-2178 (1995).
26. Bufler, J., C. Franke, H. Parnas, and J. Dudel. Open channel block by physostigmine and procaine in embryonic-like nicotinic receptors of mouse muscle. Eur. J. Neurosci. 8:677-687 (1996).
27. Sugiyama, H., Y. Hisanaga, and C. Hirono. Induction of muscarinic cholinergic responsiveness in Xenopus oocytes by mRNA isolated from rat brain. Brain Res. 338:346-350 (1985).
28. Kubo, T., K. Fukada, A. Mikami, A. Maeda, H. Takahashi, M. Mishina, T. Haga, K. Haga, A. Ichiyama, K. Kangawa, M. Kojima, M. Matsuo, H. Hirose, and S. Numa. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (Lond.) 323:411-416 (1986).
29. Kullberg, R., J. L. Owens, P. Camacho, G. Mandel, and P. Brehm. Multiple conductance classes of mouse nicotinic acetylcholine receptors expressed in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 87:2067-2071 (1990).
30. Cohen, B. N., A. Figl, M. W. Quick, C. Labarca, N. Davidson, and H. A. Lester. Regions of β2 and β4 responsible for differences between the steady state dose-response relationships of the α3β2 and α3β4 neuronal nicotinic receptors. J. Gen. Physiol. 105:745-764 (1995).
31. Peng, X., M. Katz, V. Gerzanich, R. Anand, and J. Lindstrom. Human α7 acetylcholine receptor: cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 homomers expressed in Xenopus oocytes. Mol. Pharmacol. 45:546-554 (1994).
32. Anand, R., X. Peng, and J. Lindstrom. Homomeric and native α7 acetylcholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex. FEBS Lett. 327:241-246 (1993).
33. Schrattenholz, A., E. F. R. Pereira, U. Roth, K. H. Weber, E. X. Albuquerque, and A. Maelicke. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 49:1-6 (1996).
34. Pereira, E. F. R., S. Reinhardt-Maelicke, A. Schrattenholz, A. Maelicke, and E. X. Albuquerque. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 265:1474-1491 (1993).
35. Fletcher, G. H., and J. H. Steinbach. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors. Mol. Pharmacol. 49:938-947 (1996).
36. Nooney, J. M., J. A. Peters, and J. J. Lambert. A patch clamp study of the nicotinic acetylcholine receptor of bovine adrenomedullary chromaffin cells in culture. J. Physiol. (Lond.) 455:503-527 (1992).
37. Weiner, N. Atropine, scopolamine, and related antimuscarinic drugs, in The Pharmacological Basis of Therapeutics (A. Goodman-Gilman, L. S. Goodman, T. W. Rall, and R. Murad, eds.). Pergamon Press, New York, 130-144 (1985).